Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

By  

Current Cancer Drug Targets, Vol. 6, Iss. 3, 2006-05 ,pp. : 257-269

Bentham Science Publishers

Access to resources Recommend Favorite

Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action

By Ortmann O   Weiss JM   Diedrich K  

Reproductive BioMedicine Online, Vol. 5, Iss. 3, 2002-11 ,pp. : 1-7

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Population Pharmacokinetic Modeling of a Subcutaneous Depot for GnRH Antagonist Degarelix

By Tornøe Christoffer W.   Agersø Henrik   Nielsen Henrik A.   Madsen Henrik   Jonsson E. Niclas  

Pharmaceutical Research, Vol. 21, Iss. 4, 2004-04 ,pp. : 574-584

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modellingof GnRH Antagonist Degarelix: A Comparisonof the Non-linear Mixed-Effects Programs NONMEM and NLME

By Tornøe Christoffer   Agersø Henrik   Nielsen Henrik   Madsen Henrik   Jonsson E.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 31, Iss. 6, 2004-12 ,pp. : 441-461

Springer Publishing Company

Access to resources Recommend Favorite

Structure elucidation and conformational analysis of gonadotropin releasing hormone and its novel synthetic analogue [Tyr(OMe) 5 , D-Lys 6 , Aze 9 NHEt]GnRH: The importance of aromatic clustering in the receptor binding activity

By Matsoukas J.   Keramida M.   Panagiotopoulos D.   Mavromoustakos T.   Maia H.   Bigam G.   Pati D.   Habibi H.   Moore G.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 12, 1998-12 ,pp. : 927-940

Elsevier

Access to resources Recommend Favorite